Cargando…
Randomized Trial of Treat-and-Extend Intravitreal Aflibercept for Radiation Retinopathy: 1-Year Outcomes
PURPOSE: Radiation retinopathy (RR)-related macular edema commonly causes poor visual acuity outcomes in patients previously treated with ocular radiation therapy. Current treatments are not US Food and Drug Administration (FDA)-approved and prior studies have variable outcomes. We performed a multi...
Autores principales: | Trejo Corona, Stephanie, Villanueva Boone, Cecilia, Ali, Amna M., Moore, Chelsey, Brown, Alexandra, Munoz, Jose, Aaberg, Thomas, Schefler, Amy C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10292667/ https://www.ncbi.nlm.nih.gov/pubmed/37351877 http://dx.doi.org/10.1167/iovs.64.7.35 |
Ejemplares similares
-
Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy
por: Nicholson, Luke, et al.
Publicado: (2018) -
Intravitreal Administration of AAV2-SIRT1 Reverses Diabetic Retinopathy in a Mouse Model of Type 2 Diabetes
por: Adu-Agyeiwaah, Yvonne, et al.
Publicado: (2023) -
Intravitreal anti-vascular endothelial growth factor for the treatment of chronic central serous retinopathy: a meta-analysis of the literature
por: Palakkamanil, Mathew, et al.
Publicado: (2023) -
Quantifying burden of intravitreal injections: questionnaire assessment of life impact of treatment by intravitreal injections (QUALITII)
por: Wang, Rui, et al.
Publicado: (2022) -
Extended Intravitreal Rabbit Eye Residence of Nanoparticles Conjugated With Cationic Arginine Peptides for Intraocular Drug Delivery: In Vivo Imaging
por: Melgar-Asensio, Ignacio, et al.
Publicado: (2018)